These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9480726)

  • 21. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.
    Ziegler B; Augstein P; Lühder F; Northemann W; Hamann J; Schlosser M; Klöting I; Michaelis D; Ziegler M
    Diabetes Res; 1994; 25(2):47-64. PubMed ID: 7544254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
    Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
    Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration.
    Hutchings P; Cooke A
    J Autoimmun; 1998 Apr; 11(2):127-30. PubMed ID: 9650091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies.
    Bockova J; Elias D; Cohen IR
    J Autoimmun; 1997 Aug; 10(4):323-9. PubMed ID: 9237795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal flanking residues of a diabetes-associated GAD65 determinant are necessary for activation of antigen-specific T cells in diabetes-resistant mice.
    Dai YD; Jensen KP; Marrero I; Li N; Quinn A; Sercarz EE
    Eur J Immunol; 2008 Apr; 38(4):968-76. PubMed ID: 18395850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
    Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo.
    Wilson SS; White TC; DeLuca D
    J Immunol; 2001 Jul; 167(1):569-77. PubMed ID: 11418696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
    Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
    J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals.
    Reijonen H; Elliott JF; van Endert P; Nepom G
    J Immunol; 1999 Aug; 163(3):1674-81. PubMed ID: 10415074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide.
    Chen SL; Whiteley PJ; Freed DC; Rothbard JB; Peterson LB; Wicker LS
    J Autoimmun; 1994 Oct; 7(5):635-41. PubMed ID: 7840855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
    Jaeckel E; Klein L; Martin-Orozco N; von Boehmer H
    J Exp Med; 2003 Jun; 197(12):1635-44. PubMed ID: 12796471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
    Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
    Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
    Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
    Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region.
    Marttila J; Juhela S; Vaarala O; Hyöty H; Roivainen M; Hinkkanen A; Vilja P; Simell O; Ilonen J
    Virology; 2001 May; 284(1):131-41. PubMed ID: 11352674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetes.
    Kanazawa Y; Shimada A; Oikawa Y; Okubo Y; Tada A; Imai T; Miyazaki J; Itoh H
    J Autoimmun; 2009 Mar; 32(2):104-9. PubMed ID: 19188044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes.
    Lohmann T; Leslie RD; Londei M
    J Autoimmun; 1996 Jun; 9(3):385-9. PubMed ID: 8816975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.